Condition

Gastric Cancers clinical trials and research

• 10Clinical trials
• 1NIH research projects
• 11Countries

Newest Gastric Cancers clinical trials

All recruiting trials (10)

• Gastric Cancer Clinicobiological Cohort Study

  This study tests the tumor microenvironment in gastric and gastroesophageal junction cancers from patients who had surgery after standard neoadjuvant chemotherapy at a single center.

  Recruiting Centre Leon Berard · Lyon · NCT07787052

• GEH300079 (68Ga) PET/CT scan to detect peritoneal carcinomatosis in colorectal, gastric, ovarian, and pancreatic cancers (PERISCOPE)

  This will test whether a GEH300079 (68Ga) PET/CT scan can detect peritoneal carcinomatosis in adults with colorectal, gastric, ovarian, or pancreatic ductal adenocarcinoma who have known or suspected peritoneal disease.

  Recruiting Phase 2/3 GE Healthcare · Grand Rapids, Michigan and 1 other locations · NCT07219238

• Link between psychological distress and immune therapy response in gastric cancer

  We will see if psychological distress influences how well immune checkpoint inhibitors work in adults with gastric adenocarcinoma receiving preoperative immunotherapy before surgery.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07003334

• Robotic removal of stomach tumors after pre-surgery chemotherapy for advanced gastric cancer

  This trial tests whether robotic stomach cancer surgery after 3–4 cycles of preoperative therapy is safe and helps people with stage III resectable gastric or gastroesophageal junction adenocarcinoma.

  Recruiting Phase 2 The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT06895447

• Using deep learning and Raman spectroscopy for early cancer diagnosis

  This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.

  Recruiting at 4 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Nanchang, Jiangxi and 3 other locations · NCT06822413

• QL1706 combined with SOX for treating advanced gastric cancers

  This study is testing if a new treatment combining QL1706 and SOX can help people with advanced stomach cancer before surgery and improve their chances of recovery.

  Recruiting Phase 1/2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06766305

• Lymph node spread in the short gastric mesentery after total gastrectomy for stomach cancer

  This project will examine removed short gastric mesentery tissue to see how often cancer has spread to those lymph nodes in people having total gastrectomy for gastric cancer.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06728878

• AI-assisted non-contrast CT for detecting multiple cancers

  This study is testing whether an AI tool can help find different types of cancer earlier in healthy people getting routine check-ups.

  Recruiting Changhai Hospital · Shanghai, Shanghai Municipality · NCT06632886

• BOLD-100 combined with FOLFOX for advanced solid tumors

  This study is testing if a new drug called BOLD-100 can work better with FOLFOX chemotherapy for people with advanced solid tumors like colorectal and pancreatic cancers.

  Recruiting at 26 sites Phase 1/2 Bold Therapeutics, Inc. · Santa Monica, California and 27 other locations · NCT04421820

• Collecting tissue samples from patients with various gastrointestinal cancers

  This study is collecting tissue and blood samples from patients with different gastrointestinal cancers to help researchers learn more about these diseases.

  Recruiting University of Chicago · Chicago, Illinois · NCT01416714

NIH-funded research (1)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Advanced multi-payload HER2-targeted therapies to help people with breast and stomach cancers

  A new approach uses a HER2-targeting antibody carrying multiple drug payloads to overcome resistance and improve survival in breast and gastric cancers.

  NIH research Catena Biosciences, INC. · El Cerrito, United States · NIH-11408201

Related topics

Quick answers

How many Gastric Cancers clinical trials are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in China (6 trials), United States (3 trials), Canada (1 trial), Germany (1 trial), Ireland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →